I agree ... patience ... there was the downgrade issue in late 2014 and an institutional buyer action earlier this year, both impacting.
Management has reconfirmed their revenue/profit guidance a couple of times in the last few months; Revenue around $120 Million and EBITDA margin 13% to 14%!! That relates to a PE of around 7!!
The best way to view this is that the result is now "banked" but RXP is in a "news blackout" time at the minute.. nothing new to say. The next opportunity is annual result which will confirm the guidance.
The daily sales and closing price is presented below. It appears to me that there is a disproportionate number of small parcel sales which possibly relate to retail investors who have succumbed to the lack of patience!!
...it is worth noting that the last RXP presentation contained the phrase "Pipeline of opportunities is maintaining utilisation at planned levels"...
RXP Price at posting:
56.0¢ Sentiment: Hold Disclosure: Held